NAVANAPHAR Stock Overview
Navana Pharmaceuticals Limited engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Navana Pharmaceuticals PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ৳89.70 |
52 Week High | ৳122.40 |
52 Week Low | ৳65.00 |
Beta | 0 |
1 Month Change | -3.03% |
3 Month Change | 6.28% |
1 Year Change | 33.88% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 239.77% |
Recent News & Updates
Recent updates
Shareholder Returns
NAVANAPHAR | BD Pharmaceuticals | BD Market | |
---|---|---|---|
7D | 0.9% | -2.1% | -2.1% |
1Y | 33.9% | -13.5% | -14.5% |
Return vs Industry: NAVANAPHAR exceeded the BD Pharmaceuticals industry which returned -13.5% over the past year.
Return vs Market: NAVANAPHAR exceeded the BD Market which returned -14.5% over the past year.
Price Volatility
NAVANAPHAR volatility | |
---|---|
NAVANAPHAR Average Weekly Movement | 4.9% |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 5.7% |
10% most volatile stocks in BD Market | 9.1% |
10% least volatile stocks in BD Market | 3.3% |
Stable Share Price: NAVANAPHAR has not had significant price volatility in the past 3 months.
Volatility Over Time: NAVANAPHAR's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 4,143 | Md. Shafiq | https://www.navanapharma.com |
Navana Pharmaceuticals Limited engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally. The company offers generic human health products, such as tablet, capsule, powder, cream, ointment, injection, eye and nasal drop, liquid, sachet, and oral solution; and animal health products, including vaccine, bolus, liquid, injection, water soluble powder, and premix. Navana Pharmaceuticals Limited was incorporated in 1986 and is based in Dhaka, Bangladesh.
Navana Pharmaceuticals PLC Fundamentals Summary
NAVANAPHAR fundamental statistics | |
---|---|
Market cap | ৳9.64b |
Earnings (TTM) | ৳437.70m |
Revenue (TTM) | ৳6.26b |
22.0x
P/E Ratio1.5x
P/S RatioIs NAVANAPHAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NAVANAPHAR income statement (TTM) | |
---|---|
Revenue | ৳6.26b |
Cost of Revenue | ৳3.39b |
Gross Profit | ৳2.87b |
Other Expenses | ৳2.43b |
Earnings | ৳437.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 4.07 |
Gross Margin | 45.84% |
Net Profit Margin | 6.99% |
Debt/Equity Ratio | 103.9% |
How did NAVANAPHAR perform over the long term?
See historical performance and comparison